NATURALNANO, INC. (OTCMKTS:NNAN) Files An 8-K Changes in Registrant’s Certifying Accountant
ITEM 4.01.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. |
|||
| ITEM 5.02 |
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS |
||
| ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS | ||
ITEM 4.01. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
ON ACCOUNTING AND FINANCIAL DISCLOSURE.
(a) Previous Independent Registered Public Accounting Firm
On February 16 , 2017 Scrudato Co., PA notified the Board of
Directors (the Board) of NaturalNano, Inc. (the Company)
(Scrudato) that it had determined to resign as the Company’s
independent registered public accounting firm, effective
immediately . On February 17, 2017 , the Board determined to
engage DLL CPAS LLC as its new independent registered public
accounting firm to replace Scrudato
Scrudatos reports on the Company’s financial statements for the
year ended December 31, 2015 , did not contain an adverse opinion
or disclaimer of opinion, and were not qualified or modified as
to uncertainty, audit scope, or accounting principles, except
that Scraduto reports contained an explanatory paragraph
regarding substantial doubt about the Company’s ability to
continue as a going concern.
The decision to engage DLL CPAS LLC as the Company’s new auditor
(as discussed below) was approved by the Board.
During the year ended December 31, 2016, (the date of resignation
of Scrudato ), there were no disagreements between the Company
and Scrudato on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure,
which disagreements, if not resolved to the satisfaction of
Scrudato , would have caused it to make reference to the subject
matter of the disagreement in connection with its reports on the
Company’s financial statements for such years.
The Company provided Scrudato with a copy of this Current Report
on Form 8-K prior to its filing with the Securities and Exchange
Commission (SEC), and requested Scrudato furnish the Company with
a letter addressed to the SEC stating whether it agrees with the
statements made by the Company above, and if not, stating the
respects in which it does not agree. A copy of Scrudato letter,
dated February17, 2017 is attached hereto as Exhibit 16.2.
(b) New Independent Registered Public Accounting Firm
On February 17 , 2017 , the Board determined to engage DLL CPAS
LLC as its new independent registered public accounting firm
responsible for auditing its financial statements. During the
Company’s years ended December 31, 2016, and in the subsequent
interim period through February 17, 2017, neither the Company,
nor anyone on its behalf, consulted with DLL CPAS LLC with
respect to either: (i) the application of accounting principles
to a specified transaction, either completed or proposed, or the
type of audit opinion that might be rendered on the Company’s
consolidated financial statements, and neither a written report
nor oral advice was provided to the Company by DLL CPAS LLC that
was an important factor considered by the Company in reaching a
decision as to the accounting, auditing, or financial reporting
issue; or (ii) any matter that was the subject of either a
disagreement as defined in Item 304(a)(1)(iv) of Regulation S-K
or a reportable event as described in Item 304(a)(1)(v) of
Regulation S-K.
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS;
ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;
COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
In February 2017 , the Corporation entered into Employment
Agreements with (i) Mr. Colm Wrynn – the President and Chief
Executive Officer, (2) Mr. Daniel Stelcer – the Secretary and
Chief Operating Officer, and (3) Ms. Linda Giampietro Vice
President effective as of January 1,2017, Messrs. Wrynn and
Stelcer and Ms. Giampietro have provided services to the
Corporation with minimal compensation since June 2016. Messrs.
Wrynn and Stelcer and Ms. Giampietro each is a controlling person
of the Corporation. The Agreements, provide for annual base
compensation of $120,000.00 per year and related fringe benefits.
Copies of the Agreements are annexed hereto as Exhibits 10.198 ,
10.199 and 10.200.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
| Exhibit No. | Description | |
| 10.198 |
Employment Agreement with Colm Wrynn dated as of January 1, 2017 |
|
| 10.199 |
Employment Agreement with Daniel Stelcer dated as of January 1, 2017 |
|
| 10.200 |
Employment Agreement with Linda Giampietro dated as of January 1, 2017 |
|
| 16.2 |
Letter from Scrudato Co. , P.A. to the Securities and Exchange Commission |
About NATURALNANO, INC. (OTCMKTS:NNAN)
NaturalNano, Inc. (NaturalNano) is a nanomaterials company. The Company develops and markets technologies and products that provide properties to a range of materials, such as industrial polymers, plastics and composites. The Company operates through two segments: Nanotechnology and ViralProtec. The Nanotechnology segment includes the development and commercialization of material additives based on a technology utilizing halloysite nanotubes (HNTs). The Nanotechnology segment is engaged in research, development, production and marketing of its technologies relating to the treatment and separation of nanotubes from halloysite clay and the development of related commercial applications for cosmetics, health and beauty products. The ViralProtec segment is a reseller for Ebola personal protective equipment (PPE) and ancillary supplies. The Company provides personal protective equipment for caregivers for infectious patient care. NATURALNANO, INC. (OTCMKTS:NNAN) Recent Trading Information
NATURALNANO, INC. (OTCMKTS:NNAN) closed its last trading session up +0.0091 at 0.0590 with 30,830 shares trading hands.